Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5.
Saved in:
| Title: | Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5. |
|---|---|
| Authors: | Olson, Robert1,2,3 rolson2@bccancer.bc.ca, Liu, Mitchell1,4 mliu@bccancer.bc.ca, Bergman, Alanah4 abergman@bccancer.bca, Lam, Sonya4 sonya.lam@bccancer.bc.ca, Hsu, Fred5 fhsu@bccancer.bc.ca, Mou, Benjamin6 benjamin.mou@bccancer.bc.ca, Berrang, Tanya7 tberrang@bccancer.bc.ca, Mestrovic, Ante7 amestrovic@bccancer.bc.ca, Chng, Nick3 nching@bccancer.bc.ca, Hyde, Derek6 dhyde@bccancer.bc.ca, Matthews, Quinn3 qmatthews@bcancer.bc.ca, Lund, Chad8 clund@bccancer.b.ca, Glick, Daniel7 Daniel.glick@bccancer.bc.ca, Pai, Howard7 hpai@bccancer.bc.ca, Basran, Parminder7 pbasran@bccancer.bc.ca, Carolan, Hannah4 hcarolan@bccancer.b.ca, Valev, Boris3 bvalev@bccancer.bc.ca, Lefresene, Shilo4 slefresne@bccancer.bc.ca, Tyldesley, Scott4 styldesl@bccancer.bc.ca, Schellenberg, Devin8 dschellenberg@bccancer.bc.ca |
| Source: | BMC Cancer. 10/4/2018, Vol. 18 Issue 1, p1-8. 8p. 4 Charts. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-018-4859-7 |
